Kestra Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Kestra Advisory Services's IONS Position: Q3 2026 in Review
Kestra Advisory Services increased its Ionis Pharmaceuticals (IONS) stake by 3.1% in Q3 2026, buying an estimated $7.62K and bringing the position to 4,518 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #3252.
Kestra Advisory Services first reported a position in IONS in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.03M in Q1 2021. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Kestra Advisory Services held 4,518 shares of Ionis Pharmaceuticals worth $202K as of Q3 2026.
- Kestra Advisory Services bought 134 Ionis Pharmaceuticals shares in Q3 2026, an estimated $7.62K.
- Ionis Pharmaceuticals made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #3252 holding.
- Kestra Advisory Services first reported a position in Ionis Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
- Kestra Advisory Services's Ionis Pharmaceuticals position peaked at $1.03M in Q1 2021.
- 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.